250 related articles for article (PubMed ID: 28330929)
21. Functional characterization of the SIZ/PIAS-type SUMO E3 ligases, OsSIZ1 and OsSIZ2 in rice.
Park HC; Kim H; Koo SC; Park HJ; Cheong MS; Hong H; Baek D; Chung WS; Kim DH; Bressan RA; Lee SY; Bohnert HJ; Yun DJ
Plant Cell Environ; 2010 Nov; 33(11):1923-34. PubMed ID: 20561251
[TBL] [Abstract][Full Text] [Related]
22. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
[TBL] [Abstract][Full Text] [Related]
23. PIAS1 binds p300 and behaves as a coactivator or corepressor of the transcription factor c-Myb dependent on SUMO-status.
Ledsaak M; Bengtsen M; Molværsmyr AK; Fuglerud BM; Matre V; Eskeland R; Gabrielsen OS
Biochim Biophys Acta; 2016 May; 1859(5):705-18. PubMed ID: 27032383
[TBL] [Abstract][Full Text] [Related]
24. Regulation of cold signaling by sumoylation of ICE1.
Miura K; Hasegawa PM
Plant Signal Behav; 2008 Jan; 3(1):52-3. PubMed ID: 19704769
[TBL] [Abstract][Full Text] [Related]
25. SUMOylation attenuates c-Maf-dependent IL-4 expression.
Lin BS; Tsai PY; Hsieh WY; Tsao HW; Liu MW; Grenningloh R; Wang LF; Ho IC; Miaw SC
Eur J Immunol; 2010 Apr; 40(4):1174-84. PubMed ID: 20127678
[TBL] [Abstract][Full Text] [Related]
26. The language-related transcription factor FOXP2 is post-translationally modified with small ubiquitin-like modifiers.
Estruch SB; Graham SA; Deriziotis P; Fisher SE
Sci Rep; 2016 Feb; 6():20911. PubMed ID: 26867680
[TBL] [Abstract][Full Text] [Related]
27. PIAS proteins and transcriptional regulation--more than just SUMO E3 ligases?
Sharrocks AD
Genes Dev; 2006 Apr; 20(7):754-8. PubMed ID: 16600908
[No Abstract] [Full Text] [Related]
28. Regulation of gene-activation pathways by PIAS proteins in the immune system.
Shuai K; Liu B
Nat Rev Immunol; 2005 Aug; 5(8):593-605. PubMed ID: 16056253
[TBL] [Abstract][Full Text] [Related]
29. Regulation of cytokine signaling pathways by PIAS proteins.
Shuai K
Cell Res; 2006 Feb; 16(2):196-202. PubMed ID: 16474434
[TBL] [Abstract][Full Text] [Related]
30. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases.
Jackson PK
Genes Dev; 2001 Dec; 15(23):3053-8. PubMed ID: 11731472
[No Abstract] [Full Text] [Related]
31. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
[TBL] [Abstract][Full Text] [Related]
32. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.
Tallec LP; Kirsh O; Lecomte MC; Viengchareun S; Zennaro MC; Dejean A; Lombès M
Mol Endocrinol; 2003 Dec; 17(12):2529-42. PubMed ID: 14500761
[TBL] [Abstract][Full Text] [Related]
33. The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor.
Lee J; Beliakoff J; Sun Z
Nucleic Acids Res; 2007; 35(13):4523-34. PubMed ID: 17584785
[TBL] [Abstract][Full Text] [Related]
34. Interplay between nuclear transport and ubiquitin/SUMO modifications in the regulation of cancer-related proteins.
Rodríguez JA
Semin Cancer Biol; 2014 Aug; 27():11-9. PubMed ID: 24704338
[TBL] [Abstract][Full Text] [Related]
35. The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.
Chandhoke AS; Chanda A; Karve K; Deng L; Bonni S
Oncotarget; 2017 Mar; 8(13):21001-21014. PubMed ID: 28423498
[TBL] [Abstract][Full Text] [Related]
36. SUMOylation by the E3 ligase TbSIZ1/PIAS1 positively regulates VSG expression in Trypanosoma brucei.
López-Farfán D; Bart JM; Rojas-Barros DI; Navarro M
PLoS Pathog; 2014 Dec; 10(12):e1004545. PubMed ID: 25474309
[TBL] [Abstract][Full Text] [Related]
37. Targeting SUMOylation in cancer.
Du L; Liu W; Rosen ST
Curr Opin Oncol; 2021 Sep; 33(5):520-525. PubMed ID: 34280172
[TBL] [Abstract][Full Text] [Related]
38. [Negative regulation of the JAK/STAT: pathway implication in tumorigenesis].
Espert L; Dusanter-Fourt I; Chelbi-Alix MK
Bull Cancer; 2005 Oct; 92(10):845-57. PubMed ID: 16266868
[TBL] [Abstract][Full Text] [Related]
39. Disturbed flow: p53 SUMOylation in the turnover of endothelial cells.
Takabe W; Alberts-Grill N; Jo H
J Cell Biol; 2011 May; 193(5):805-7. PubMed ID: 21624951
[TBL] [Abstract][Full Text] [Related]
40. SUMOylation homeostasis in tumorigenesis.
Xie M; Yu J; Ge S; Huang J; Fan X
Cancer Lett; 2020 Jan; 469():301-309. PubMed ID: 31705931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
